001     299831
005     20250323015718.0
020 _ _ |a 978-1-0716-4425-6 (print)
020 _ _ |a 978-1-0716-4426-3 (electronic)
024 7 _ |a 10.1007/978-1-0716-4426-3_6
|2 doi
024 7 _ |a pmid:40082352
|2 pmid
024 7 _ |a 1064-3745
|2 ISSN
024 7 _ |a 1940-6029
|2 ISSN
024 7 _ |a DOI:10.1007/978-1-0716-4426-3_6
|2 doi
024 7 _ |a DOI:10.1007/978-1-0716-4426-3_6
|2 doi
024 7 _ |a altmetric:175185761
|2 altmetric
037 _ _ |a DKFZ-2025-00568
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Logotheti, Stella
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a The DNA Damage Response as an Auxiliary Indicator of Senescence in Cancer: A User-Friendly Toolkit of Markers and Detection Methods.
260 _ _ |a Totowa, NJ
|c 2025
|b Humana Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Book
|0 PUB:(DE-HGF)3
|2 PUB:(DE-HGF)
|m book
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1742291942_3582
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:E041#
520 _ _ |a Senescence is a cellular stress response causing a stable exit from the cell cycle. Limitation of cell proliferation is accompanied by a variety of characteristic changes, including cellular and nuclear morphological alterations, chromatin rearrangements, metabolic reprogramming, nuclear envelope rupture, and an immunomodulatory secretome, termed senescence-associated secreted phenotype (SASP). Senescence is a robust mechanism of tissue homeostasis, with crucial roles in eliminating dysfunctional and/or premalignant cells, and tissue repair. Activation of oncogenes triggers senescence, which in turn arrests DNA-damaged cells. This type of response, known as oncogene-induced senescence (OIS) is a powerful barrier to oncogenesis. However, in specific contexts, senescent cells support tumor progression, mainly via their secretome-mediated activities. The dynamic, context-dependent and ambivalent nature of senescence challenges the identification, characterization, and specific targeting of senescent cells for disease management. Importantly, senescence is highly intertwined with DNA damage response and repair (DDR/R) machinery that safeguards genome integrity. DNA damage events are frequently prevalent, while DDR/R signaling pathways are active during cellular senescence. In this regard, it can serve as an auxiliary indicator for senescent cells. In this chapter, we emphasize DDR/R as a shared hallmark of cancer and senescence. We provide a wieldy toolkit of experimental methods for monitoring DDR-related senescence markers, and we demonstrate the potential of using natural language processing to extract additional DDR/R biomarkers tailored to specific cancer types. Our methodologies can facilitate a comprehensive study of senescence in aging and cancer.
536 _ _ |a 315 - Bildgebung und Radioonkologie (POF4-315)
|0 G:(DE-HGF)POF4-315
|c POF4-315
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef Book Series, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Biomarkers
|2 Other
650 _ 7 |a DNA Damage Response (DDR)
|2 Other
650 _ 7 |a DNA damage
|2 Other
650 _ 7 |a Damage Response and Repair (DDR/R)
|2 Other
650 _ 7 |a Microscopy
|2 Other
650 _ 7 |a Senescence
|2 Other
650 _ 7 |a Biomarkers, Tumor
|2 NLM Chemicals
650 _ 7 |a Biomarkers
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Cellular Senescence: genetics
|2 MeSH
650 _ 2 |a DNA Damage
|2 MeSH
650 _ 2 |a Neoplasms: genetics
|2 MeSH
650 _ 2 |a Neoplasms: metabolism
|2 MeSH
650 _ 2 |a Neoplasms: pathology
|2 MeSH
650 _ 2 |a DNA Repair
|2 MeSH
650 _ 2 |a Senescence-Associated Secretory Phenotype
|2 MeSH
650 _ 2 |a Biomarkers, Tumor: metabolism
|2 MeSH
650 _ 2 |a Biomarkers, Tumor: genetics
|2 MeSH
650 _ 2 |a Cell Line, Tumor
|2 MeSH
650 _ 2 |a Biomarkers
|2 MeSH
700 1 _ |a Vasilopoulos, Spyridon N
|b 1
700 1 _ |a Tremi, Ioanna
|b 2
700 1 _ |a Gkikoudi, Angeliki
|b 3
700 1 _ |a Fragkos, Michalis
|b 4
700 1 _ |a Pavlopoulou, Athanasia
|b 5
700 1 _ |a Havaki, Sophia
|b 6
700 1 _ |a Georgakilas, Alexandros G
|b 7
773 _ _ |a DOI:10.1007/978-1-0716-4426-3_6
|0 PERI:(DE-600)2493551-7
|p 83-112
|t Methods in molecular biology
|v 2906
|y 2025
|x 1064-3745
909 C O |o oai:inrepo02.dkfz.de:299831
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-315
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Bildgebung und Radioonkologie
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-19
920 1 _ |0 I:(DE-He78)E041-20160331
|k E041
|l Med. Physik in der Radioonkologie
|x 0
920 0 _ |0 I:(DE-He78)E041-20160331
|k E041
|l Med. Physik in der Radioonkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a book
980 _ _ |a I:(DE-He78)E041-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21